These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2891533)

  • 1. Flosequinan as a third agent for the treatment of hypertension: a placebo controlled, double-blind study.
    Cowley AJ; Wynne RD; Hampton JR
    Eur J Clin Pharmacol; 1987; 33(2):203-4. PubMed ID: 2891533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine tablet vs. hydralazine in patients with persisting hypertension who receive combined diuretic and beta-blocker therapy.
    Myers MG; Leenen FH; Burns R; Frankel D
    Clin Pharmacol Ther; 1986 Apr; 39(4):409-13. PubMed ID: 2869849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diuretic, beta-adrenoceptor blocking agent and their combination on elevated blood pressure and serum potassium: a cross-over study.
    Neuvonen PJ; Pentikäinen PJ; Jounela AJ
    Br J Clin Pharmacol; 1978 Oct; 6(4):363-7. PubMed ID: 29653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of acebutolol to diuretics in hypertension.
    Gorkin JU; Elijovich F; Dziedzic SW; Krakoff LR
    Clin Pharmacol Ther; 1981 Dec; 30(6):739-44. PubMed ID: 6118215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
    Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonist.
    Cameron HA; Waller PC; Ramsay LE
    Br J Clin Pharmacol; 1987 Dec; 24(6):705-11. PubMed ID: 2894215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of flosequinan on exercise capacity and symptoms in severe heart failure.
    Elborn JS; Stanford CF; Nicholls DP
    Br Heart J; 1989 Apr; 61(4):331-5. PubMed ID: 2653391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute systemic and renal haemodynamic effects and long-term antihypertensive action of cadralazine in patients pretreated with beta-blockers and diuretics.
    Persson B; Granerus G; Wysocki M; Hedner T; Andersson OK
    Eur J Clin Pharmacol; 1987; 31(5):513-8. PubMed ID: 2881788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG
    Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tertatolol International Multicenter Study (T.I.M.S.). Predicting factors of an efficient therapy.
    Agnes E; Vandermercken C; Prost JF; Safar ME
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):296S-302S. PubMed ID: 2573379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of flosequinan on exercise capacity and cardiac function in patients with chronic mild heart failure: a double-blind placebo-controlled study.
    Hori M; Sato H; Ozaki H; Inoue M; Naka M; Fukunami M; Fukushima M; Kunisada K
    Heart Vessels; 1992; 7(3):133-40. PubMed ID: 1500398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study.
    Packer M; Narahara KA; Elkayam U; Sullivan JM; Pearle DL; Massie BM; Creager MA
    J Am Coll Cardiol; 1993 Jul; 22(1):65-72. PubMed ID: 8509565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-over factorial studies with antihypertensive drugs.
    Wing LM; Chalmers JP; West MJ
    Nephron; 1987; 47 Suppl 1():94-8. PubMed ID: 2892143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
    Freis ED
    Am Heart J; 1984 Oct; 108(4 Pt 2):1087-91. PubMed ID: 6148868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ketanserin on blood pressure and biochemical parameters in patients with essential hypertension.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S164-7. PubMed ID: 2412043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STOP-Hypertension--preliminary communication from the pilot study of the Swedish Trial in Old Patients with Hypertension.
    Dahlöf B; Hansson L; Lindholm L; Schersten B; Wester PO
    J Hypertens Suppl; 1987 Dec; 5(5):S607-10. PubMed ID: 2895171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ketanserin and slow-release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta-adrenoceptor blocker.
    Waller PC; Solomon SA; Ramsay LE
    Br J Clin Pharmacol; 1987 Nov; 24(5):591-7. PubMed ID: 2893636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.
    Chen JM; Heran BS; Perez MI; Wright JM
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.